NEW YORK, Dec. 13 — Pharsight and Roche Bioscience will collaborate to link Roche’s genomics discovery program with Pharsight’s software, modeling, and simulation technologies for clinical drug development, the companies said Thursday. The partnership is intended to apply genetic analysis to clinical trials and drug development in order to spur research into individually tailored drugs. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more